Lina Perafan Valdes

Lina Perafan Valdes

Auto-generated profile, based on publicly available information

Lina Perafan Valdes

Universidad Libre, Programa de Maestría en Epidemiología, Cali, Colombia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in The Application of Clinical Genetics
Verified
Journal Article
Open access
PDF file
HPHarry Pachajoa
Harry Pachajoa
ACAngelica Claros-Hulbert
Angelica Claros-Hulbert
Ximena GarciaXimena Garcia
Ximena Garcia
LPLina Perafan
Lina Perafan
ARAndres Ramirez
Andres Ramirez
AZAndres F Zea-Vera
Andres F Zea-Vera
Hutchinson–Gilford progeria syndrome (HGPS) is a rare congenital disease caused by mutations in the LMNA gene. Children with HGPS are phenotypically characterized by lipodystrophy, short height, low body weight, scleroderma, reduced joint mobility, osteolysis, senile facial features, and cardiovascular compromise that usually lead to death. We aimed to describe the case of a patient who reached above-average age expectancy for children with HGPS in Latin America and describe the clinical and molecular characteristics of the patient. A 14-year-old female patient was presented with progeria-compatible phenotypic characteristics. HGPS was confirmed via LMNA gene sequencing that detected a heterozygous c.1824C>T (p.Gly608Gly) mutation. The primary aim is to describe the HGPS case, the molecular gene mutation finding, and make a short review of the limited available treatment options for children with HGPS. Such as the farnesyl transferase inhibitors in conjunction with other pharmacological therapies that have insinuated improvement in health, and survival rate.

1 August 2020 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
HPHarry Pachajoa
Harry Pachajoa
LVLina Perafan Valdes
Lina Perafan Valdes
IRIsabella Ramos
Isabella Ramos
ÁEÁlvaro J Escobar
Álvaro J Escobar
Trisomy 20p is a chromosomal anomaly resulting from whole or partial duplication of the short arm of chromosome 20. It is a rarely reported syndrome and it is estimated that there are only a few cases of this condition worldwide, which hampers the phenotypic characterization of this entity. Conversely, müllerian anomalies include a group of congenital malformations of the uterus, vagina, cervix, and fallopian tubes resulting from alterations in the embryological development of the müllerian ducts. We report a case of pure trisomy 20p diagnosed using array comparative genomic hybridization (CGH) accompanied by a müllerian anomaly in a female patient with abnormal growth pattern, round face, coarse hair, broad nose, long palpebral fissure, epicanthus, and megaureter.

25 October 2022 in Pharmacogenomics and Personalized Medicine
Verified
Journal Article
Open access
PDF file
LPLina Perafan-Valdes
Lina Perafan-Valdes
SGSebastian Giraldo-Ocampo
Sebastian Giraldo-Ocampo
JLJuliana Lores
Juliana Lores
HPHarry Pachajoa
Harry Pachajoa
Neurofibromatosis type 1 is one of the most common genetic autosomal dominant disorders described, with a prevalence of 1 in 2000 to 1 in 3000 individuals. It is characterized by skin, nerves, and bone abnormalities. Non-related to NF1, hypospadias is a displacement in the urethral opening which in the majority of patients has an idiopathic cause. Here, we describe a patient with neurofibromatosis type 1, hypospadias, and unilateral cryptorchidism. The heterozygous variants c.6789_6792delTTAC, p.(Tyr2264Thrfs*5) and c.140A>G, p.(Tyr47Cys) were found in the NF1 and NR5A1 genes, respectively. This case contributes to the phenotypical characterization of patients with NF1 but also with hypospadias caused by a mutation in the NR5A1 gene, which usually leads to severe sex disorders.